
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.8M | $5.1M | $7M | $7.8M | $6.9M | |
Revenue Growth (YoY) | 25.11% | 80.29% | 37.26% | 10.47% | -10.64% | |
Cost of Revenues | $794.8K | $1.7M | $2.4M | $6.3M | $1.3M | |
Gross Profit | $2M | $3.4M | $4.6M | $1.4M | $5.6M | |
Gross Profit Margin | 71.98% | 67.29% | 65.25% | 18.46% | 81.39% | |
R&D Expenses | $1.4M | $2.4M | $3.3M | $2.4M | $2.5M | |
Selling, General & Admin | $5.8M | $6M | $9.4M | $7.9M | $7.1M | |
Other Inc / (Exp) | -$499.1K | -$50K | -$2.3M | $377.2K | -$13K | |
Operating Expenses | $6.9M | $8.4M | $13.1M | $10.3M | $9.7M | |
Operating Income | -$4.9M | -$5M | -$8.5M | -$8.8M | -$4M | |
Net Interest Expenses | $4.3M | $13.9K | $1.2M | $206.7K | $299.6K | |
EBT. Incl. Unusual Items | -$9.7M | -$5.1M | -$11.9M | -$8.7M | -$4.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -$20.4K | -$134K | -$23K | |
Net Income to Company | -$9.7M | -$5.1M | -$11.9M | -$8.5M | -$4.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$9.7M | -$5.1M | -$11.9M | -$8.5M | -$4.3M | |
Basic EPS (Cont. Ops) | -$37.44 | -$11.70 | -$27.26 | -$15.21 | -$2.09 | |
Diluted EPS (Cont. Ops) | -$37.44 | -$11.70 | -$27.26 | -$15.21 | -$2.09 | |
Weighted Average Basic Share | $261.2K | $432.9K | $436.8K | $560.3K | $2.1M | |
Weighted Average Diluted Share | $261.2K | $432.9K | $436.8K | $560.3K | $2.1M | |
EBITDA | -$4.9M | -$4.5M | -$11.4M | -$8M | -$3.7M | |
EBIT | -$5.3M | -$5M | -$11.9M | -$8.4M | -$4.1M | |
Revenue (Reported) | $2.8M | $5.1M | $7M | $7.8M | $6.9M | |
Operating Income (Reported) | -$4.9M | -$5M | -$8.5M | -$8.8M | -$4M | |
Operating Income (Adjusted) | -$5.3M | -$5M | -$11.9M | -$8.4M | -$4.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.9M | $1.9M | $2.2M | $2.2M | $1.6M | |
Revenue Growth (YoY) | 261.47% | 2.78% | 12.5% | -0.12% | -26.32% | |
Cost of Revenues | $766.6K | $337.4K | $1.3M | $299.6K | $279.5K | |
Gross Profit | $1.1M | $1.6M | $863.5K | $1.9M | $1.3M | |
Gross Profit Margin | 59.41% | 82.62% | 39.54% | 86.26% | 82.61% | |
R&D Expenses | $441.7K | $805.3K | $690.2K | $607.5K | $595.8K | |
Selling, General & Admin | $1.5M | $1.8M | $1.9M | $1.8M | $1.4M | |
Other Inc / (Exp) | -- | -- | $127K | -- | -- | |
Operating Expenses | $2M | $2.6M | $2.6M | $2.4M | $2M | |
Operating Income | -$836.1K | -$999.5K | -$1.8M | -$508.9K | -$640.6K | |
Net Interest Expenses | $15.4K | -- | $56.9K | $1.4K | $95.9K | |
EBT. Incl. Unusual Items | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Basic EPS (Cont. Ops) | -$1.98 | -$2.34 | -$3.51 | -$0.32 | -$0.16 | |
Diluted EPS (Cont. Ops) | -$1.98 | -$2.34 | -$3.51 | -$0.32 | -$0.16 | |
Weighted Average Basic Share | $431.9K | $438.1K | $480.8K | $1.6M | $4.7M | |
Weighted Average Diluted Share | $431.9K | $438.1K | $480.8K | $1.6M | $4.7M | |
EBITDA | -$754.3K | -$882.4K | -$1.5M | -$407.1K | -$602.6K | |
EBIT | -$833.4K | -$999.4K | -$1.6M | -$508.9K | -$700.6K | |
Revenue (Reported) | $1.9M | $1.9M | $2.2M | $2.2M | $1.6M | |
Operating Income (Reported) | -$836.1K | -$999.5K | -$1.8M | -$508.9K | -$640.6K | |
Operating Income (Adjusted) | -$833.4K | -$999.4K | -$1.6M | -$508.9K | -$700.6K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.2M | $5.2M | $7.3M | $7.8M | $6.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.4M | $1.2M | $3.4M | $5.3M | $1.3M | |
Gross Profit | $2.8M | $3.9M | $3.8M | $2.4M | $5.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $1.5M | $2.7M | $3.1M | $2.3M | $2.5M | |
Selling, General & Admin | $6M | $6.3M | $9.5M | $7.7M | $6.7M | |
Other Inc / (Exp) | -- | -$50K | $127K | $250.2K | -- | |
Operating Expenses | $7.1M | $9.1M | $13.1M | $10M | $9.2M | |
Operating Income | -$4.4M | -$5.2M | -$9.2M | -$7.6M | -$4.1M | |
Net Interest Expenses | $2.8M | -- | $1.2M | $151.2K | $394.2K | |
EBT. Incl. Unusual Items | -$7.2M | -$5.2M | -$12.6M | -$7.5M | -$4.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -$20.4K | -$134K | -$23K | |
Net Income to Company | -$7.2M | -$5.2M | -$12.6M | -$7.3M | -$4.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$7.2M | -$5.2M | -$12.6M | -$7.3M | -$4.5M | |
Basic EPS (Cont. Ops) | -$25.20 | -$12.06 | -$23.67 | -$12.67 | -$2.08 | |
Diluted EPS (Cont. Ops) | -$25.20 | -$12.06 | -$23.67 | -$12.67 | -$2.08 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$3.9M | -$4.7M | -$12M | -$6.9M | -$3.9M | |
EBIT | -$4.3M | -$5.2M | -$12.6M | -$7.3M | -$4.3M | |
Revenue (Reported) | $4.2M | $5.2M | $7.3M | $7.8M | $6.4M | |
Operating Income (Reported) | -$4.4M | -$5.2M | -$9.2M | -$7.6M | -$4.1M | |
Operating Income (Adjusted) | -$4.3M | -$5.2M | -$12.6M | -$7.3M | -$4.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.9M | $1.9M | $2.2M | $2.2M | $1.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $766.6K | $337.4K | $1.3M | $299.6K | $279.5K | |
Gross Profit | $1.1M | $1.6M | $863.5K | $1.9M | $1.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $441.7K | $805.3K | $690.2K | $607.5K | $595.8K | |
Selling, General & Admin | $1.5M | $1.8M | $1.9M | $1.8M | $1.4M | |
Other Inc / (Exp) | -- | -- | $127K | -- | -- | |
Operating Expenses | $2M | $2.6M | $2.6M | $2.4M | $2M | |
Operating Income | -$836.1K | -$999.5K | -$1.8M | -$508.9K | -$640.6K | |
Net Interest Expenses | $15.4K | -- | $56.9K | $1.4K | $95.9K | |
EBT. Incl. Unusual Items | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Basic EPS (Cont. Ops) | -$1.98 | -$2.34 | -$3.51 | -$0.32 | -$0.16 | |
Diluted EPS (Cont. Ops) | -$1.98 | -$2.34 | -$3.51 | -$0.32 | -$0.16 | |
Weighted Average Basic Share | $431.9K | $438.1K | $480.8K | $1.6M | $4.7M | |
Weighted Average Diluted Share | $431.9K | $438.1K | $480.8K | $1.6M | $4.7M | |
EBITDA | -$754.3K | -$882.4K | -$1.5M | -$407.1K | -$602.6K | |
EBIT | -$833.4K | -$999.4K | -$1.6M | -$508.9K | -$700.6K | |
Revenue (Reported) | $1.9M | $1.9M | $2.2M | $2.2M | $1.6M | |
Operating Income (Reported) | -$836.1K | -$999.5K | -$1.8M | -$508.9K | -$640.6K | |
Operating Income (Adjusted) | -$833.4K | -$999.4K | -$1.6M | -$508.9K | -$700.6K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $17M | $7.8M | $2.6M | $511.4K | $437.6K | |
Short Term Investments | $512.8K | -- | -- | -- | -- | |
Accounts Receivable, Net | $548.1K | $970.6K | $1.5M | $1.2M | $718.2K | |
Inventory | $331K | $4.9M | $4.4M | $445.7K | $378.3K | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $201.5K | $216K | $342.7K | $364.2K | $278.7K | |
Total Current Assets | $18.9M | $14M | $9M | $2.6M | $1.9M | |
Property Plant And Equipment | $569.1K | $323.3K | $304.8K | $257.1K | $213.6K | |
Long-Term Investments | -- | $452.8K | -- | -- | $5M | |
Goodwill | $1.3M | $1.3M | -- | -- | -- | |
Other Intangibles | $1.6M | $1.3M | $1.8M | $1.4M | $1.1M | |
Other Long-Term Assets | $8.7K | $8.7K | $8.7K | -- | $8K | |
Total Assets | $22.5M | $17.8M | $11.3M | $4.5M | $8.6M | |
Accounts Payable | $244.2K | $427.8K | $1.1M | $1.3M | $818.2K | |
Accrued Expenses | $403.9K | $516K | $606.6K | $807.6K | $655.4K | |
Current Portion Of Long-Term Debt | -- | -- | $2.7M | $138.7K | $132.7K | |
Current Portion Of Capital Lease Obligations | $234.3K | $177.2K | $159.7K | $37.8K | $24.6K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.9M | $2M | $5.5M | $3.2M | $4.6M | |
Long-Term Debt | -- | -- | $326.8K | $188.8K | $44.8K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.2M | $2.2M | $6M | $3.5M | $4.8M | |
Common Stock | $780 | $790 | $60 | $100 | $370 | |
Other Common Equity Adj | -- | -- | -$242.6K | $22.8K | $49.3K | |
Common Equity | $20.3M | $15.6M | $5.3M | $1.1M | $3.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $20.3M | $15.6M | $5.3M | $1.1M | $3.8M | |
Total Liabilities and Equity | $22.5M | $17.8M | $11.3M | $4.5M | $8.6M | |
Cash and Short Terms | $17.5M | $7.8M | $2.6M | $511.4K | $437.6K | |
Total Debt | $232K | -- | $3M | $327.5K | $1.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $13.5M | $5.8M | $722.3K | $690.5K | $3.1M | |
Short Term Investments | $512.8K | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.4M | $2.6M | $3.4M | $701.8K | $803.3K | |
Inventory | $600.5K | $5M | $4.4M | $440.2K | $357.8K | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.6M | $361.4K | $341.2K | $427.7K | $254.3K | |
Total Current Assets | $17.7M | $13.8M | $8.9M | $2.3M | $4.6M | |
Property Plant And Equipment | $500.2K | $331.7K | $225.4K | $221.5K | $190.1K | |
Long-Term Investments | -- | $452.8K | -- | -- | $5M | |
Goodwill | $1.3M | $1.7M | -- | -- | -- | |
Other Intangibles | $1.5M | $2.7M | $1.7M | -- | -- | |
Other Long-Term Assets | $8.7K | $8.7K | $8.7K | -- | $8K | |
Total Assets | $21.5M | $19.4M | $11.1M | $4.2M | $11.2M | |
Accounts Payable | $309.3K | $1M | $1.2M | $1.2M | $568.8K | |
Accrued Expenses | $536K | $895.5K | $876.3K | $1.2M | $1M | |
Current Portion Of Long-Term Debt | -- | $123K | $2.6M | $135.8K | $138.7K | |
Current Portion Of Capital Lease Obligations | $230.1K | $156.7K | $96.6K | $23.8K | $25.3K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.6M | $3.5M | $5.4M | $3.3M | $3.5M | |
Long-Term Debt | -- | $423.7K | $277.6K | $149.9K | $11.7K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.9M | $4M | $5.9M | $3.6M | $3.7M | |
Common Stock | $780 | $840 | $920 | $180 | $580 | |
Other Common Equity Adj | -- | $55.8K | -$170.5K | -$39.5K | $56.1K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $19.6M | $15.4M | $5.2M | $535.7K | $7.5M | |
Total Liabilities and Equity | $21.5M | $19.4M | $11.1M | $4.2M | $11.2M | |
Cash and Short Terms | $14M | $5.8M | $722.3K | $690.5K | $3.1M | |
Total Debt | -- | $546.7K | $2.9M | $285.7K | $912.5K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9.7M | -$5.1M | -$11.9M | -$8.5M | -$4.3M | |
Depreciation & Amoritzation | $426.9K | $514.1K | $546K | $429.7K | $477.5K | |
Stock-Based Compensation | $792.1K | $314.7K | $387.9K | $265.7K | $243.3K | |
Change in Accounts Receivable | -$186.8K | -$661.6K | -$339.4K | -$478.6K | $881K | |
Change in Inventories | $98.2K | -$4.6M | $106.3K | $402.1K | $280.4K | |
Cash From Operations | -$5M | -$9M | -$6.2M | -$3.8M | -$2.9M | |
Capital Expenditures | $35.6K | $42K | $82K | $1K | $13K | |
Cash Acquisitions | -$1.9M | -- | -$623.6K | -- | -- | |
Cash From Investing | -$2.2M | -$42K | -$696.6K | -$1K | -$13.1K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4M | -- | $2M | -- | $2M | |
Long-Term Debt Repaid | -$4.9M | -$250K | -- | -$2.3M | -$912.6K | |
Repurchase of Common Stock | -- | -- | -- | -$561.4K | -$172.4K | |
Other Financing Activities | -$2.7M | -$5.2K | -$155.1K | -$561.4K | -$172.4K | |
Cash From Financing | $24.1M | -$218.6K | $1.9M | $1.4M | $2.8M | |
Beginning Cash (CF) | $79K | $17M | $7.8M | $2.6M | $511.4K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $16.9M | -$9.2M | -$5M | -$2.4M | -$100.3K | |
Ending Cash (CF) | $17M | $7.8M | $2.6M | $511.4K | $437.6K | |
Levered Free Cash Flow | -$5M | -$9M | -$6.3M | -$3.8M | -$2.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Depreciation & Amoritzation | $79.1K | $117K | $94.5K | $101.8K | $98K | |
Stock-Based Compensation | $141.2K | $109.7K | $71.4K | $56.8K | $61.5K | |
Change in Accounts Receivable | -$873.6K | -$907.3K | -$931.9K | $490.8K | -$51.3K | |
Change in Inventories | -$269.5K | -$15.8K | $6.6K | $5.6K | $20.5K | |
Cash From Operations | -$3.2M | -$1.4M | -$1.9M | $297.1K | -$835.3K | |
Capital Expenditures | $13.3K | $4.5K | -- | $1.9K | $4.6K | |
Cash Acquisitions | -- | -$543.6K | -- | -- | -- | |
Cash From Investing | -$13.3K | -$545K | -- | -$1.9K | -$4.6K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$250K | -- | -$34.3K | -$41.8K | -$35.1K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.7K | -- | -- | -$13.5K | -$248.8K | |
Cash From Financing | -$252.7K | -- | -$34.3K | -$53.9K | $3.5M | |
Beginning Cash (CF) | $17M | $7.8M | $2.6M | $511.4K | $437.6K | |
Foreign Exchange Rate Adjustment | -- | $26.5K | $49.9K | -$62.3K | $6.8K | |
Additions / Reductions | -$3.5M | -$2M | -$2M | $241.3K | $2.7M | |
Ending Cash (CF) | $13.5M | $5.8M | $722.3K | $690.5K | $3.1M | |
Levered Free Cash Flow | -$3.2M | -$1.4M | -$1.9M | $295.2K | -$839.9K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$7.2M | -$5.2M | -$12.6M | -$7.3M | -$4.5M | |
Depreciation & Amoritzation | $479K | $552K | $523.5K | $437K | $473.7K | |
Stock-Based Compensation | $420.5K | $283.3K | $349.6K | $251.2K | $247.9K | |
Change in Accounts Receivable | -$1M | -$695.4K | -$364K | $944.1K | $338.8K | |
Change in Inventories | -$202.7K | -$4.4M | $128.7K | $401.1K | $295.4K | |
Cash From Operations | -$7.1M | -$7.2M | -$6.7M | -$1.6M | -$4M | |
Capital Expenditures | $48.9K | $33.2K | $77.6K | $1.9K | $15.7K | |
Cash Acquisitions | -$1.9M | -$543.6K | -$80K | -- | -- | |
Cash From Investing | -$2.2M | -$573.8K | -$151.6K | -$2.9K | -$15.7K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$5.1M | -- | -$34.3K | -$2.3M | -$905.9K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.7M | -- | -- | -- | -$407.7K | |
Cash From Financing | $22.2M | $34.1K | $1.9M | $1.4M | $6.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $12.9M | -$7.8M | -$5M | -$156.6K | $2.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$7.2M | -$7.2M | -$6.8M | -$1.6M | -$4.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$851.4K | -$999.4K | -$1.7M | -$510.3K | -$736.6K | |
Depreciation & Amoritzation | $79.1K | $117K | $94.5K | $101.8K | $98K | |
Stock-Based Compensation | $141.2K | $109.7K | $71.4K | $56.8K | $61.5K | |
Change in Accounts Receivable | -$873.6K | -$907.3K | -$931.9K | $490.8K | -$51.3K | |
Change in Inventories | -$269.5K | -$15.8K | $6.6K | $5.6K | $20.5K | |
Cash From Operations | -$3.2M | -$1.4M | -$1.9M | $297.1K | -$835.3K | |
Capital Expenditures | $13.3K | $4.5K | -- | $1.9K | $4.6K | |
Cash Acquisitions | -- | -$543.6K | -- | -- | -- | |
Cash From Investing | -$13.3K | -$545K | -- | -$1.9K | -$4.6K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$250K | -- | -$34.3K | -$41.8K | -$35.1K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.7K | -- | -- | -$13.5K | -$248.8K | |
Cash From Financing | -$252.7K | -- | -$34.3K | -$53.9K | $3.5M | |
Beginning Cash (CF) | $17M | $7.8M | $2.6M | $511.4K | $437.6K | |
Foreign Exchange Rate Adjustment | -- | $26.5K | $49.9K | -$62.3K | $6.8K | |
Additions / Reductions | -$3.5M | -$2M | -$2M | $241.3K | $2.7M | |
Ending Cash (CF) | $13.5M | $5.8M | $722.3K | $690.5K | $3.1M | |
Levered Free Cash Flow | -$3.2M | -$1.4M | -$1.9M | $295.2K | -$839.9K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.